81_FR_4932 81 FR 4914 - Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Early Food Safety Evaluation of New Non-Pesticidal Proteins Produced by New Plant Varieties Intended for Food Use

81 FR 4914 - Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Early Food Safety Evaluation of New Non-Pesticidal Proteins Produced by New Plant Varieties Intended for Food Use

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration

Federal Register Volume 81, Issue 18 (January 28, 2016)

Page Range4914-4914
FR Document2016-01686

The Food and Drug Administration (FDA) is announcing that a collection of information entitled ``Early Food Safety Evaluation of New Non-Pesticidal Proteins Produced by New Plant Varieties Intended for Food Use'' has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.

Federal Register, Volume 81 Issue 18 (Thursday, January 28, 2016)
[Federal Register Volume 81, Number 18 (Thursday, January 28, 2016)]
[Notices]
[Page 4914]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-01686]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2012-N-0438]


Agency Information Collection Activities; Announcement of Office 
of Management and Budget Approval; Early Food Safety Evaluation of New 
Non-Pesticidal Proteins Produced by New Plant Varieties Intended for 
Food Use

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing that a 
collection of information entitled ``Early Food Safety Evaluation of 
New Non-Pesticidal Proteins Produced by New Plant Varieties Intended 
for Food Use'' has been approved by the Office of Management and Budget 
(OMB) under the Paperwork Reduction Act of 1995.

FOR FURTHER INFORMATION CONTACT: FDA PRA Staff, Office of Operations, 
Food and Drug Administration, 8455 Colesville Rd., COLE-14526, Silver 
Spring, MD 20993-0002, PRAStaff@fda.hhs.gov.

SUPPLEMENTARY INFORMATION: On October 8, 2015, the Agency submitted a 
proposed collection of information entitled ``Early Food Safety 
Evaluation of New Non-Pesticidal Proteins Produced by New Plant 
Varieties Intended for Food Use'' to OMB for review and clearance under 
44 U.S.C. 3507. An Agency may not conduct or sponsor, and a person is 
not required to respond to, a collection of information unless it 
displays a currently valid OMB control number. OMB has now approved the 
information collection and has assigned OMB control number 0910-0583. 
The approval expires on November 30, 2018. A copy of the supporting 
statement for this information collection is available on the Internet 
at http://www.reginfo.gov/public/do/PRAMain.

    Dated: January 22, 2016.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2016-01686 Filed 1-27-16; 8:45 am]
 BILLING CODE 4164-01-P



                                             4914                         Federal Register / Vol. 81, No. 18 / Thursday, January 28, 2016 / Notices

                                             ComplianceRegulatoryInformation/                         TABLE 1—NEW DRAFT PRODUCT-SPE- DEPARTMENT OF HEALTH AND
                                             Guidances/default.htm.                                    CIFIC BE RECOMMENDATIONS FOR HUMAN SERVICES
                                                As described in that guidance, FDA                     DRUG PRODUCTS—Continued
                                             adopted this process as a means to                                                                             Food and Drug Administration
                                             develop and disseminate product-                        Spinosad.
                                             specific BE recommendations and                         Trametinib dimethyl sulfoxide.                         [Docket No. FDA–2012–N–0438]
                                             provide a meaningful opportunity for                    Vorapaxar sulfate.
                                             the public to consider and comment on                                                                          Agency Information Collection
                                             those recommendations. Under that                       III. Drug Products for Which Revised                   Activities; Announcement of Office of
                                             process, draft recommendations are                      Draft Product-Specific BE                              Management and Budget Approval;
                                             posted on FDA’s Web site and                            Recommendations are Available                          Early Food Safety Evaluation of New
                                             announced periodically in the Federal                                                                          Non-Pesticidal Proteins Produced by
                                             Register. The public is encouraged to                      FDA is announcing the availability of
                                                                                                     a revised draft guidance for industry on               New Plant Varieties Intended for Food
                                             submit comments on those                                                                                       Use
                                             recommendations within 60 days of                       product-specific BE recommendations
                                             their announcement in the Federal                       for drug products containing the
                                                                                                                                                            AGENCY:   Food and Drug Administration,
                                             Register. FDA considers any comments                    following active ingredients:
                                                                                                                                                            HHS.
                                             received and either publishes final
                                             recommendations or publishes revised                      TABLE 2—REVISED DRAFT PRODUCT-                       ACTION:   Notice.
                                             draft recommendations for comment.                         SPECIFIC BE RECOMMENDATIONS
                                             Recommendations were last announced                        FOR DRUG PRODUCTS                                   SUMMARY:   The Food and Drug
                                             in the Federal Register on September                                                                           Administration (FDA) is announcing
                                             21, 2015 (80 FR 57000). This notice                     Abiraterone acetate.                                   that a collection of information entitled
                                             announces draft product-specific                        Amphotericin B.                                        ‘‘Early Food Safety Evaluation of New
                                             recommendations, either new or                          Ciprofloxacin hydrochloride; hydrocortisone.           Non-Pesticidal Proteins Produced by
                                             revised, that are posted on FDA’s Web                   Colesevelam hydrochloride.                             New Plant Varieties Intended for Food
                                             site.                                                   Drospirenone; estradiol.                               Use’’ has been approved by the Office of
                                                                                                     Guanfacine hydrochloride.                              Management and Budget (OMB) under
                                             II. Drug Products for Which New Draft
                                                                                                     Lidocaine.                                             the Paperwork Reduction Act of 1995.
                                             Product-Specific BE Recommendations
                                                                                                     Lomitapide mesylate.
                                             are Available                                                                                                  FOR FURTHER INFORMATION CONTACT:    FDA
                                                                                                     Methylphenidate hydrochloride.
                                               FDA is announcing the availability of                 Phytonadione.                                          PRA Staff, Office of Operations, Food
                                             new draft guidances for industry on                     Rivastigmine tartrate.                                 and Drug Administration, 8455
                                             product-specific BE recommendations                                                                            Colesville Rd., COLE–14526, Silver
                                             for drug products containing the                   For a complete history of previously                        Spring, MD 20993–0002,
                                             following active ingredients:                   published Federal Register notices                             PRAStaff@fda.hhs.gov.
                                                                                             related to product-specific BE
                                              TABLE 1—NEW DRAFT PRODUCT-SPE- recommendations, go to http://                                                 SUPPLEMENTARY INFORMATION:     On
                                                CIFIC BE RECOMMENDATIONS FOR www.regulations.gov and enter Docket                                           October 8, 2015, the Agency submitted
                                                DRUG PRODUCTS                                                                                               a proposed collection of information
                                                                                             No. FDA–2007–D–0369.
                                                                                                                                                            entitled ‘‘Early Food Safety Evaluation
                                             Alprostadil.
                                                                                                These draft guidances are being                             of New Non-Pesticidal Proteins
                                             Atazanavir sulfate; cobicistat.                 issued consistent with FDA’s good                              Produced by New Plant Varieties
                                             Beclomethasone dipropionate.                    guidance practices regulation (21 CFR                          Intended for Food Use’’ to OMB for
                                             Betamethasone dipropionate.                     10.115). These draft guidances, when                           review and clearance under 44 U.S.C.
                                             Betamethasone valerate.                         finalized, will represent the current                          3507. An Agency may not conduct or
                                             Betaxolol hydrochloride.                        thinking of FDA on the product-specific
                                             Ciclesonide.                                                                                                   sponsor, and a person is not required to
                                                                                             design of BE studies to support ANDAs.
                                             Clobetasol propionate.                                                                                         respond to, a collection of information
                                                                                             They do not establish any rights for any
                                             Desonide (multiple reference listed drugs).                                                                    unless it displays a currently valid OMB
                                                                                             person and are not binding on FDA or
                                             Diflorasone diacetate (multiple reference list-                                                                control number. OMB has now
                                               ed drugs).                                    the public. You can use an alternative
                                                                                                                                                            approved the information collection and
                                             Difluprednate emulsion.                         approach if it satisfies the requirements
                                                                                             of the applicable statutes and                                 has assigned OMB control number
                                             Elvitegravir.
                                             Erythromycin.                                   regulations.                                                   0910–0583. The approval expires on
                                             Ethinyl estradiol; norethindrone acetate.                                                                      November 30, 2018. A copy of the
                                             Flurandrenolide.                                        II. Electronic Access                                  supporting statement for this
                                             Formoterol fumarate; mometasone furoate.                                                                       information collection is available on
                                             Ingenol mebutate (multiple strengths).                    Persons with access to the Internet
                                                                                                                                                            the Internet at http://www.reginfo.gov/
                                             Mercaptopurine.                                         may obtain the draft guidance at either
                                                                                                                                                            public/do/PRAMain.
                                             Methylphenidate hydrocholoride.                         http://www.fda.gov/Drugs/Guidance
                                             Metronidazole.                                          ComplianceRegulatoryInformation/                         Dated: January 22, 2016.
                                             Mometasone furoate.                                     Guidances/default.htm or http://                       Leslie Kux,
wgreen on DSK2VPTVN1PROD with NOTICES




                                             Naftifine hydrochloride (multiple reference             www.regulations.gov.                                   Associate Commissioner for Policy.
                                               listed drugs).
                                             Nicotine.                                                 Dated: January 22, 2016.                             [FR Doc. 2016–01686 Filed 1–27–16; 8:45 am]
                                             Olanzapine pamoate.                                     Leslie Kux,                                            BILLING CODE 4164–01–P
                                             Omega-3-carboxylic acids.                               Associate Commissioner for Policy.
                                             Prednisone.
                                             Ranitidine hydrochloride.                               [FR Doc. 2016–01682 Filed 1–27–16; 8:45 am]
                                             Riociguat.                                              BILLING CODE 4164–01–P




                                        VerDate Sep<11>2014   13:19 Jan 27, 2016   Jkt 238001   PO 00000   Frm 00008   Fmt 4703   Sfmt 9990   E:\FR\FM\28JAN1.SGM   28JAN1



Document Created: 2018-02-02 12:41:03
Document Modified: 2018-02-02 12:41:03
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice.
ContactFDA PRA Staff, Office of Operations, Food and Drug Administration, 8455 Colesville Rd., COLE-14526, Silver Spring, MD 20993-0002, [email protected]
FR Citation81 FR 4914 

2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR